Skip to main content

Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism

Journal Article


Download full-text (Open Access)

Abstract


  • Abstracts from the XXVII CINP Congress, 6–10 June 2010, Hong Kong

Publication Date


  • 2010

Citation


  • Weston-Green, K., Huang, X. F., Kang, K. & Deng, C. (2010). Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism. International Journal of Neuropsychopharmacology, 13 (Supplement S1), 111-112.

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=1993&context=sspapers

Ro Metadata Url


  • http://ro.uow.edu.au/sspapers/994

Number Of Pages


  • 1

Start Page


  • 111

End Page


  • 112

Volume


  • 13

Issue


  • Supplement S1

Place Of Publication


  • United Kingdom

Abstract


  • Abstracts from the XXVII CINP Congress, 6–10 June 2010, Hong Kong

Publication Date


  • 2010

Citation


  • Weston-Green, K., Huang, X. F., Kang, K. & Deng, C. (2010). Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism. International Journal of Neuropsychopharmacology, 13 (Supplement S1), 111-112.

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=1993&context=sspapers

Ro Metadata Url


  • http://ro.uow.edu.au/sspapers/994

Number Of Pages


  • 1

Start Page


  • 111

End Page


  • 112

Volume


  • 13

Issue


  • Supplement S1

Place Of Publication


  • United Kingdom